Order-of-mutation effects on cancer progression: models for myeloproliferative neoplasm
arXiv:2308.09941 · doi:10.1007/s11538-024-01257-5
Abstract
We develop a modeling framework for cancer progression that distinguishes the order of two possible mutations. Recent observations and information on myeloproliferative neoplasms are analyzed within our framework. In some patients with myeloproliferative neoplasms, two genetic mutations can be found, JAK2 V617F and TET2. Whether or not one mutation is present will influence how the other subsequent mutation affects the regulation of gene expression. When both mutations are present, the order of their occurrence has been shown to influence disease progression and prognosis. In this paper, we propose a nonlinear ordinary differential equation (ODE) and Markov chain models to explain the non-additive and non-commutative clinical observations with respect to different orders of mutations: gene expression patterns, proportions of cells with different mutations, and ages at diagnosis. We also propose potential experiments measurements that can be used to verify our models.
arXiv comment22 pp, 7 figures. arXiv admin note: text overlap with arXiv:2302.07955
References in corpus (6)
- Accumulation of driver and passenger mutations during tumor progression
- A multi-phenotypic cancer model with cell plasticity
- The overshoot and phenotypic equilibrium in characterizing cancer dynamics of reversible phenotypic plasticity
- The phenotypic equilibrium of cancer cells: From average-level stability to path-wise convergence
- Phenotypic Equilibrium as Probabilistic Convergence in Multi-phenotype Cell Population Dynamics
- Mathematical Representation of Clausius' and Kelvin's Statements of the Second Law and Irreversibility